Prevalence, Management, and Outcome of Lupus Nephritis: A Ten Years Systematic Review

Prevalence, Management, and Outcome of Lupus Nephritis

A Ten Years Systematic Review

Authors

  • Daniel Setiawan Nathan Maranatha Christian University
  • Charles Sanjaya Internal Medicine Consultant, Kebonjati General Hospital

Keywords:

Lupus, nephritis, prevalence, managemnet, kidney

Abstract

Background: Lupus nephritis (LN) occurs in ~50% of patients with SLE and is the most common, but not the only, cause of kidney injury in SLE. Men with SLE tend to have more aggressive disease with higher rates of renal and cardiovascular involvement and are more likely to develop kidney failure than women. Methods: This systematic review focused on full-text English literature published between 2014 and 2024 using the PRISMA 2020 guidelines. Editorials and review pieces published in the same journal as the submission without a DOI were not accepted. The literature was compiled using PubMed, ScienceDirect, and SagePub, among other online venues. Result: Five publications were found to be directly related to our ongoing systematic examination after a rigorous three-level screening approach. Subsequently, a comprehensive analysis of the complete text was conducted, and additional scrutiny was given to these articles. Conclusion: Achieving a complete clinical response to treatment is critical to preserving long-term kidney health.

References

Lao C, Van Dantzig P, White D, Rabindranath K, Foxall D, Lawrenson R. Prevalence and outcomes of end-stage kidney disease in patients with systemic lupus erythematous: a population-based study. Rheumatol Int [Internet]. 2024;44(3):469–75. Available from: https://doi.org/10.1007/s00296-023-05409-z

Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update in the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14–25.

Hoover NE, Ouranos HB, Memon S, Azemi T, Piccirillo BJ, Sadiq IR, et al. Transcarotid Versus Transfemoral Transcatheter Aortic Valve Replacement (from a Propensity-Matched Comparison). Am J Cardiol [Internet]. 2022;185:71–9. Available from: https://doi.org/10.1016/j.amjcard.2022.09.003

Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: Results from an international inception cohort study. Rheumatol (United Kingdom). 2015;55(2):252–62.

Askanase AD, Dall’Era M, Almaani S. Insights into future management of lupus nephritis. Front Lupus [Internet]. 2024;2(February). Available from: https://doi.org/10.3389/flupu.2024.1334932

Tamirou F, Houssiau FA. Management of Lupus Nephritis. J Clin Med [Internet]. 2021 Feb 9;10(4):670. Available from: https://www.mdpi.com/2077-0383/10/4/670

Gasparotto M, Gatto M, Binda V, Doria A, Moroni G. Lupus nephritis: Clinical presentations and outcomes in the 21st century. Rheumatol (United Kingdom). 2020;59:V39–51.

Hailu GMT, Hussen SU, Getachew S, Berha AB. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. BMC Nephrol [Internet]. 2022;23(1):1–14. Available from: https://doi.org/10.1186/s12882-022-02846-z

Aliyi O, Worku B, Hassen M, Muhammed OS. Treatment outcome and survival status among adult patients treated for lupus nephritis in selected tertiary hospitals of Ethiopia. Sci Rep [Internet]. 2024;14(1):1–13. Available from: https://doi.org/10.1038/s41598-024-56317-6

Mongkolchaiarunya J, Wongthanee A, Kasitanon N, Louthrenoo W. Comparison of Clinical Features, Treatment and Outcomes of Lupus Nephritis Between Patients With Late- and Early-Onset Systemic Lupus Erythematosus: A Controlled Study. J Clin Med Res [Internet]. 2024;16(2–3):106–17. Available from: https://www.doi.org/10.14740/jocmr5097

Abbasi MSR, Sultan K, Naeemullah N, Mushtaq A, Saleem H, Khan QU, et al. the Prevalence of Different Classes of Lupus Nephritis Based on Isn/Rpn 2003 Classification System Keeping Renal Biopsy As Standard for Diagnosis. J Popul Ther Clin Pharmacol. 2023;30(17):1644–51.

Shao SJ, Hou JH, Xie GT, Sun W, Liang DD, Zeng CH, et al. Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010. J Rheumatol [Internet]. 2019 Aug;46(8):912–9. Available from: http://www.jrheum.org/lookup/doi/10.3899/jrheum.180145

Hongyan L, Yi Z, Bao D, Yuewu L, Juan M. A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review. Clin Dev Immunol. 2013;2013(January 2009):1–6.

Yap DYH, Chan TM. Lupus Nephritis in Asia: Clinical Features and Management. Kidney Dis. 2015;1(2):100–9.

Parikh S V., Almaani S, Brodsky S, Rovin BH. Update on Lupus Nephritis: Core Curriculum 2020. Am J Kidney Dis [Internet]. 2020;76(2):265–81. Available from: https://doi.org/10.1053/j.ajkd.2019.10.017

Published

2024-04-10

Issue

Section

Articles

How to Cite

Setiawan Nathan, Daniel, and Charles Sanjaya. 2024. “Prevalence, Management, and Outcome of Lupus Nephritis: A Ten Years Systematic Review”. The International Journal of Medical Science and Health Research 1 (1): 60-73. https://internationalmedicaljournal.org/index.php/ijmhsr/article/view/5.